To Assess the Efficacy and Safety of the Cardio Formulation in Reducing Oxidized LDL

NCT04317287 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped COVID-19 Pandemic

Conditions

Oxidized Low Density Lipoprotein

Interventions

DIETARY_SUPPLEMENT: Cardio formulation
DIETARY_SUPPLEMENT: Placebo

Sponsor

Supplement Formulators, Inc.